Select Page

AUSTIN, Texas, Oct. 15, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that it has been invited to participate in the Cancer Innovation Summit. The meeting, which is hosted by Health Tech Austin, is being held virtually on Thursday, October 22 from 12.00 to 3.00 p.m. EDT.
Gregory Stein, M.D., Senior Vice President of Clinical Development at Plus Therapeutics will present as part of the Cancer Drug Showcase, which features novel cancer technologies from across the industry.Register for the meeting webcast here: https://www.eventbrite.com/e/the-cancer-innovation-summit-registration-123138597861?aff=erellivmltThe Cancer Innovation Summit brings together thought leaders and innovators to share knowledge, experience, research and insights about cancer innovation.About Plus Therapeutics, Inc.Plus Therapeutics (Nasdaq: PSTV) is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets. Central to the Company’s drug development is a unique nanotechnology platform designed to reformulate, deliver and commercialize multiple drugs targeting rare cancers and other diseases. The platform is designed to facilitate new delivery approaches and/or formulations of safe and effective, injectable drugs, potentially enhancing the safety, efficacy and convenience for patients and healthcare providers. More information may be found at plustherapeutics.com and respect-trials.com.Cautionary Statement Regarding Forward-Looking Statements